Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Varun Garg

Clinical Cardiac Electrophysiology Milwaukee, WI Doctor of Osteopathy

NPI 1124434683 CMS profile 1164150

2350 N Lake Dr Ste 206, Milwaukee, WI 53211

Open in the dashboard

General payments

$43,393

224 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Varun Garg of Milwaukee, WI is reported in the CMS Open Payments database as having received $43,393 across 224 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,590 20
2024 General $7,052 38
2023 General $5,116 19
2022 General $3,609 59
2021 General $2,376 25
2020 General $13,750 10
2019 General $1,899 53

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Varun Garg
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Varun Garg were reported at $9,590. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Varun Garg Clinical Cardiac Electrophysiology median Middle half National median
2019 $1,899 $2,361 $585–$8,260 $163
2020 $13,750 $993 $247–$4,351 $114
2021 $2,376 $1,185 $326–$4,739 $132
2022 $3,609 $2,073 $554–$6,789 $149
2023 $5,116 $2,568 $759–$8,159 $160
2024 $7,052 $2,557 $703–$7,403 $164
2025 $9,590 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $19,579 102 payments
  2. Medtronic Vascular, Inc. $8,333 1 payment
  3. Biosense Webster, Inc. $6,562 25 payments
  4. Boston Scientific Corporation $5,233 5 payments
  5. Abbott Laboratories $1,153 18 payments
  6. Medical Device Business Services, Inc. $950 9 payments
  7. Biotronik Inc. $523 9 payments
  8. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $382 12 payments
  9. Janssen Pharmaceuticals, Inc $231 18 payments
  10. Amgen Inc. $79 4 payments
  11. Other $368 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Grant $14,669 3 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,750 7 payments
  3. Travel and Lodging $7,181 39 payments
  4. Food and Beverage $6,581 170 payments
  5. Consulting Fee $4,500 1 payment
  6. Education $712 4 payments
Products named General payments · program years 2019–2025
  1. Micra $5,716 42 payments
  2. GENERAL - BRADY $5,000 1 payment
  3. Carto 3 $1,961 20 payments
  4. EVERA MRI XT DR SURESCAN $1,842 14 payments
  5. Carto 3 System $1,004 11 payments
  6. HeartMate 3 Left Ventricular Dev $424 2 payments
  7. LifeVest $382 12 payments
  8. ENSITE PRECISION $312 3 payments
  9. AURORA EV-ICD MRI SURESCAN $311 3 payments
  10. Rivacor $303 6 payments
  11. Other $3,176 105 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

938

Median for Cardiology: 2,533

Drug cost

$446,386

Median for Cardiology: $485,213

Branded share of claims

40.2%

Median for Cardiology: 25.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 271 $330,807
Xarelto Rivaroxaban Brand 67 $62,975
Multaq Dronedarone Hcl Brand 20 $42,968
Amiodarone Hcl Generic 182 $4,239
Metoprolol Succinate Generic 163 $1,965
Flecainide Acetate Generic 42 $1,874
Metoprolol Tartrate Generic 116 $796
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 19 $367
Carvedilol Generic 29 $199
Omeprazole Generic 29 $196

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,782 Part D prescribers listed as Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$68,730

Medicare's payments for the services billed

Medicare patients

615

Average age 76

Services billed

1,458

312 women, 303 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 50%
Ischemic heart disease 48%
Atrial fibrillation 46%
Heart failure 42%
Chronic kidney disease 37%
Diabetes 33%
Depression 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

224 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record